logo
HCV/ HIV co-infection
Hepatic inflammatory cytokine mRNA expression in hepatitis C virus–human immunodeficiency virus co-infection
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease
Hepatitis C virus core protein binding to lipid membranes
Modelling hepatitis C virus kinetics during treatment with pegylated interferon α-2b
Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment
Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b
Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5
MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma
Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B